Oncoxin® and Quality of Life in Cancer Patients

Clinical trial NCT03550482 · COMPLETED

Trial details

NCT number: NCT03550482
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastric Cancer Stage II Non-small Cell Lung Cancer Stage II Non-small Cell Lung Cancer Stage III Gastric Cancer Stage III

Start date: 2017-11-01
Primary completion: 2019-03-15
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.